1: GO: Molecular Function [Display Chart]
301 annotations before applied cutoff / 18819 genes in category
|
2: GO: Biological Process [Display Chart]
1668 annotations before applied cutoff / 18785 genes in category
|
3: GO: Cellular Component [Display Chart]
142 annotations before applied cutoff / 19172 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0020005
|
symbiont-containing vacuole membrane
|
|
2.616E-4
|
2.204E-2
|
1.220E-1
|
3.714E-2
|
2
|
6
|
2
|
GO:0020003
|
symbiont-containing vacuole
|
|
3.652E-4
|
2.204E-2
|
1.220E-1
|
5.186E-2
|
2
|
7
|
3
|
GO:0065010
|
extracellular membrane-bounded organelle
|
|
6.226E-4
|
2.204E-2
|
1.220E-1
|
8.841E-2
|
2
|
9
|
4
|
GO:0033655
|
host cell cytoplasm part
|
|
7.761E-4
|
2.204E-2
|
1.220E-1
|
1.102E-1
|
2
|
10
|
5
|
GO:0030430
|
host cell cytoplasm
|
|
7.761E-4
|
2.204E-2
|
1.220E-1
|
1.102E-1
|
2
|
10
|
6
|
GO:0033646
|
host intracellular part
|
|
1.132E-3
|
2.296E-2
|
1.271E-1
|
1.608E-1
|
2
|
12
|
7
|
GO:0043656
|
intracellular region of host
|
|
1.132E-3
|
2.296E-2
|
1.271E-1
|
1.608E-1
|
2
|
12
|
8
|
GO:0033643
|
host cell part
|
|
1.552E-3
|
2.755E-2
|
1.526E-1
|
2.204E-1
|
2
|
14
|
9
|
GO:0018995
|
host
|
|
2.877E-3
|
4.086E-2
|
2.262E-1
|
4.086E-1
|
2
|
19
|
10
|
GO:0043657
|
host cell
|
|
2.877E-3
|
4.086E-2
|
2.262E-1
|
4.086E-1
|
2
|
19
|
11
|
GO:0042022
|
interleukin-12 receptor complex
|
|
4.225E-3
|
4.337E-2
|
2.401E-1
|
5.999E-1
|
1
|
1
|
12
|
GO:1990425
|
ryanodine receptor complex
|
|
4.225E-3
|
4.337E-2
|
2.401E-1
|
5.999E-1
|
1
|
1
|
13
|
GO:0044217
|
other organism part
|
|
4.581E-3
|
4.337E-2
|
2.401E-1
|
6.505E-1
|
2
|
24
|
14
|
GO:0044215
|
other organism
|
|
4.581E-3
|
4.337E-2
|
2.401E-1
|
6.505E-1
|
2
|
24
|
15
|
GO:0044216
|
other organism cell
|
|
4.581E-3
|
4.337E-2
|
2.401E-1
|
6.505E-1
|
2
|
24
|
Show 10 more annotations
|
4: Human Phenotype [Display Chart]
239 annotations before applied cutoff / 4410 genes in category
|
5: Mouse Phenotype [Display Chart]
1171 annotations before applied cutoff / 9299 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
MP:0002462
|
abnormal granulocyte physiology
|
|
5.889E-5
|
4.520E-2
|
3.455E-1
|
6.896E-2
|
7
|
258
|
2
|
MP:0004003
|
abnormal vascular endothelial cell physiology
|
|
7.719E-5
|
4.520E-2
|
3.455E-1
|
9.039E-2
|
4
|
58
|
|
6: Domain [Display Chart]
520 annotations before applied cutoff / 18735 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
PF02544
|
Steroid dh
|
Pfam
|
1.922E-4
|
3.332E-2
|
2.277E-1
|
9.997E-2
|
2
|
5
|
2
|
PS50244
|
S5A REDUCTASE
|
PROSITE
|
1.922E-4
|
3.332E-2
|
2.277E-1
|
9.997E-2
|
2
|
5
|
3
|
IPR001104
|
3-oxo-5 a-steroid 4-DH C
|
InterPro
|
1.922E-4
|
3.332E-2
|
2.277E-1
|
9.997E-2
|
2
|
5
|
4
|
PF15040
|
Humanin
|
Pfam
|
8.527E-4
|
4.913E-2
|
3.356E-1
|
4.434E-1
|
2
|
10
|
5
|
PF02841
|
GBP C
|
Pfam
|
8.527E-4
|
4.913E-2
|
3.356E-1
|
4.434E-1
|
2
|
10
|
6
|
IPR028139
|
Humanin
|
InterPro
|
8.527E-4
|
4.913E-2
|
3.356E-1
|
4.434E-1
|
2
|
10
|
7
|
PS51715
|
G GB1 RHD3
|
PROSITE
|
1.039E-3
|
4.913E-2
|
3.356E-1
|
5.404E-1
|
2
|
11
|
8
|
IPR003191
|
Guanylate-bd C
|
InterPro
|
1.039E-3
|
4.913E-2
|
3.356E-1
|
5.404E-1
|
2
|
11
|
9
|
IPR030386
|
G GB1 RHD3 dom
|
InterPro
|
1.039E-3
|
4.913E-2
|
3.356E-1
|
5.404E-1
|
2
|
11
|
10
|
IPR015894
|
Guanylate-bd N
|
InterPro
|
1.039E-3
|
4.913E-2
|
3.356E-1
|
5.404E-1
|
2
|
11
|
11
|
PF02263
|
GBP
|
Pfam
|
1.039E-3
|
4.913E-2
|
3.356E-1
|
5.404E-1
|
2
|
11
|
Show 6 more annotations
|
7: Pathway [Display Chart]
284 annotations before applied cutoff / 10916 genes in category
|
8: Pubmed [Display Chart]
8486 annotations before applied cutoff / 51853 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
19623253
|
Humanin: a novel central regulator of peripheral insulin action.
|
Pubmed
|
1.421E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
9
|
2
|
16689661
|
In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters.
|
Pubmed
|
1.421E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
9
|
3
|
20542501
|
Immunolocalization of humanin in human sperm and testis.
|
Pubmed
|
1.421E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
9
|
4
|
25630734
|
The human mitochondrial genome may code for more than 13 proteins.
|
Pubmed
|
1.774E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
10
|
5
|
23402768
|
Humanin: a harbinger of mitochondrial-derived peptides?
|
Pubmed
|
1.774E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
10
|
6
|
12732850
|
Humanin peptide suppresses apoptosis by interfering with Bax activation.
|
Pubmed
|
2.166E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
11
|
7
|
20639880
|
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis.
|
Pubmed
|
2.595E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
12
|
8
|
19477263
|
Evidence for potential functionality of nuclearly-encoded humanin isoforms.
|
Pubmed
|
3.063E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
13
|
9
|
12009529
|
Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults.
|
Pubmed
|
3.063E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
13
|
10
|
19260141
|
Genome-wide association study of biochemical traits in Korcula Island, Croatia.
|
Pubmed
|
3.569E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
14
|
11
|
11371646
|
A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.
|
Pubmed
|
3.569E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
14
|
12
|
23455924
|
A Y2H-seq approach defines the human protein methyltransferase interactome.
|
Pubmed
|
6.537E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
5
|
342
|
13
|
23149075
|
Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.
|
Pubmed
|
6.663E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
19
|
14
|
19377476
|
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.
|
Pubmed
|
8.161E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
21
|
15
|
15167446:gr
|
Genetic analysis of 22 candidate genes for hypertension in the Japanese population.
|
GeneRIF
|
8.965E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
22
|
16
|
15167446
|
Genetic analysis of 22 candidate genes for hypertension in the Japanese population.
|
Pubmed
|
8.965E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
22
|
17
|
22939624
|
Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.
|
Pubmed
|
9.403E-4
|
3.962E-3
|
3.813E-2
|
1.000E0
|
5
|
371
|
18
|
20395963:gr
|
Replication of genetic association studies in asthma and related phenotypes.
|
GeneRIF
|
1.255E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
26
|
19
|
20395963
|
Replication of genetic association studies in asthma and related phenotypes.
|
Pubmed
|
1.255E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
26
|
20
|
24667918
|
Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02 AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.
|
Pubmed
|
1.266E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
3
|
105
|
21
|
22082156
|
A whole genome screen for HIV restriction factors.
|
Pubmed
|
1.373E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
3
|
108
|
22
|
8012384
|
Purification of CpG islands using a methylated DNA binding column.
|
Pubmed
|
1.456E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
2
|
28
|
23
|
20139978
|
Genome-wide association study of hematological and biochemical traits in a Japanese population.
|
Pubmed
|
1.727E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
3
|
117
|
24
|
18809751:gr
|
Cathepsin C gene variants in aggressive periodontitis.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
25
|
17879019:gr
|
Serum adiponectin levels and lifestyle factors in Japanese men.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
26
|
12736161
|
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
27
|
12925300
|
Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
28
|
12029075:gr
|
Localization of heparanase in normal and pathological human placenta.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
29
|
17189871:gr
|
Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
30
|
17370067
|
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
31
|
18243321:gr
|
The leukocyte receptor CD84 inhibits Fc epsilon RI-mediated signaling through homophilic interaction in transfected RBL-2H3 cells.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
32
|
20686181
|
Adiponectin stimulates glucose uptake in rabbit blastocysts.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
33
|
22792409:gr
|
Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
34
|
19426893
|
Plasma adiponectin levels are associated with insulin sensitivity in stroke survivors.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
35
|
22719918:gr
|
An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
36
|
19696691
|
Low serum adiponectin levels are associated with systemic organ failure in acute pancreatitis.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
37
|
19326438
|
The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
38
|
22535972:gr
|
Iodotyrosine deiodinase defect identified via genome-wide approach.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
39
|
24893580
|
Lack of association between TESPA1 gene polymorphisms (rs1801876, rs2171497, rs4758994, and rs997173) and ankylosing spondylitis in a Chinese population.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
40
|
25065557
|
Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
41
|
18187960:gr
|
Expression of platelet-activating factor receptor: a novel prognosticator in patients with hepatocellular carcinoma following hepatectomy.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
42
|
17184520:gr
|
Regional age-related changes in neuronal nitric oxide synthase (nNOS), messenger RNA levels and activity in SAMP8 brain.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
43
|
25481860
|
Evaluation of salivary adiponectin profile in obese patients.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
44
|
22927754:gr
|
Association of plasma adiponectin levels with cellular hydration state measured using bioelectrical impedance analysis in patients with COPD.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
45
|
7678401
|
Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
46
|
15380304:gr
|
Immunohistochemical study of the distribution of neuronal voltage-gated calcium channels in the nNOS knock-out mouse cerebellum.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
47
|
22239938
|
ADIPOQ gene polymorphisms and susceptibility to polycystic ovary syndrome: a HuGE survey and meta-analysis.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
48
|
11112111
|
Exhaled nitric oxide in patients with asthma: association with NOS1 genotype.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
49
|
8395240
|
Isolation and properties of platelet-activating factor receptor cDNAs.
|
Pubmed
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
50
|
17524042:gr
|
Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
|
GeneRIF
|
2.006E-3
|
3.962E-3
|
3.813E-2
|
1.000E0
|
1
|
1
|
Show 45 more annotations
|
9: Interaction [Display Chart]
763 annotations before applied cutoff / 16534 genes in category
|
10: Cytoband [Display Chart]
95 annotations before applied cutoff / 34661 genes in category
|
11: Transcription Factor Binding Site [Display Chart]
225 annotations before applied cutoff / 9770 genes in category
|
12: Gene Family [Display Chart]
56 annotations before applied cutoff / 18194 genes in category
|
13: Coexpression [Display Chart]
3550 annotations before applied cutoff / 21867 genes in category
|
14: Coexpression Atlas [Display Chart]
1900 annotations before applied cutoff / 20974 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
26Dp SubClass 26Dp 3 Top 500 All
|
26Dp SubClass 26Dp 3 Top 500 All
|
Brain Map - Allen iN
|
8.639E-42
|
1.641E-38
|
1.334E-37
|
1.641E-38
|
41
|
464
|
2
|
54Dp SubClass 54Dp 1SK Top 500 All
|
54Dp SubClass 54Dp 1SK Top 500 All
|
Brain Map - Allen iN
|
1.499E-39
|
9.495E-37
|
7.717E-36
|
2.848E-36
|
39
|
443
|
3
|
54Dp SubClass 54Dp 1SK Top 500 Cluster 0
|
54Dp SubClass 54Dp 1SK Top 500 Cluster 0
|
Brain Map - Allen iN
|
1.499E-39
|
9.495E-37
|
7.717E-36
|
2.848E-36
|
39
|
443
|
4
|
54Dn SubClass 54Dn 5 Top 500 All
|
54Dn SubClass 54Dn 5 Top 500 All
|
Brain Map - Allen iN
|
7.229E-32
|
3.434E-29
|
2.790E-28
|
1.373E-28
|
34
|
453
|
5
|
80Dp SubClass 80Dp 5 Top 500 All
|
80Dp SubClass 80Dp 5 Top 500 All
|
Brain Map - Allen iN
|
1.215E-31
|
4.619E-29
|
3.754E-28
|
2.309E-28
|
34
|
460
|
6
|
26Dn SubClass 26Dn 3 Top 500 All
|
26Dn SubClass 26Dn 3 Top 500 All
|
Brain Map - Allen iN
|
2.526E-27
|
8.000E-25
|
6.502E-24
|
4.800E-24
|
31
|
467
|
7
|
26Dp SubClass 26Dp 3 Top 500 Cluster 3
|
26Dp SubClass 26Dp 3 Top 500 Cluster 3
|
Brain Map - Allen iN
|
1.065E-25
|
2.891E-23
|
2.350E-22
|
2.024E-22
|
22
|
172
|
8
|
54Dn SubClass 54Dn 5 Top 500 Cluster 4
|
54Dn SubClass 54Dn 5 Top 500 Cluster 4
|
Brain Map - Allen iN
|
1.864E-20
|
4.426E-18
|
3.597E-17
|
3.541E-17
|
18
|
153
|
9
|
80Dp SubClass 80Dp 5 Top 500 Cluster 0
|
80Dp SubClass 80Dp 5 Top 500 Cluster 0
|
Brain Map - Allen iN
|
8.390E-20
|
1.771E-17
|
1.439E-16
|
1.594E-16
|
18
|
166
|
10
|
26Dn SubClass 26Dn 3 Top 500 Cluster 4
|
26Dn SubClass 26Dn 3 Top 500 Cluster 4
|
Brain Map - Allen iN
|
2.083E-18
|
3.958E-16
|
3.216E-15
|
3.958E-15
|
17
|
164
|
11
|
54Dp SubClass 54Dp 5 Top 500 All
|
54Dp SubClass 54Dp 5 Top 500 All
|
Brain Map - Allen iN
|
4.458E-13
|
7.699E-11
|
6.257E-10
|
8.469E-10
|
19
|
460
|
12
|
26Dp SubClass 26Dp 3 Top 500 Cluster 4
|
26Dp SubClass 26Dp 3 Top 500 Cluster 4
|
Brain Map - Allen iN
|
2.463E-11
|
3.900E-9
|
3.170E-8
|
4.680E-8
|
11
|
129
|
13
|
54Dn SubClass 54Dn 5 Top 500 Cluster 0
|
54Dn SubClass 54Dn 5 Top 500 Cluster 0
|
Brain Map - Allen iN
|
9.291E-9
|
1.358E-6
|
1.104E-5
|
1.765E-5
|
10
|
173
|
14
|
80Dp SubClass 80Dp 5 Top 500 Cluster 2
|
80Dp SubClass 80Dp 5 Top 500 Cluster 2
|
Brain Map - Allen iN
|
1.765E-8
|
2.395E-6
|
1.947E-5
|
3.353E-5
|
10
|
185
|
15
|
80Dn SubClass 80Dn 5 Top 500 All
|
80Dn SubClass 80Dn 5 Top 500 All
|
Brain Map - Allen iN
|
4.928E-8
|
5.852E-6
|
4.756E-5
|
9.363E-5
|
14
|
474
|
16
|
80Dn SubClass 80Dn 5 Top 500 Cluster 0
|
80Dn SubClass 80Dn 5 Top 500 Cluster 0
|
Brain Map - Allen iN
|
4.928E-8
|
5.852E-6
|
4.756E-5
|
9.363E-5
|
14
|
474
|
17
|
26Dn SubClass 26Dn 3 Top 500 Cluster 1
|
26Dn SubClass 26Dn 3 Top 500 Cluster 1
|
Brain Map - Allen iN
|
1.381E-7
|
1.543E-5
|
1.254E-4
|
2.623E-4
|
9
|
174
|
18
|
54Dp SubClass 54Dp 5 Top 500 Cluster 0
|
54Dp SubClass 54Dp 5 Top 500 Cluster 0
|
Brain Map - Allen iN
|
1.562E-7
|
1.649E-5
|
1.340E-4
|
2.968E-4
|
8
|
127
|
19
|
54Dn SubClass 54Dn 5 Top 500 Cluster 2
|
54Dn SubClass 54Dn 5 Top 500 Cluster 2
|
Brain Map - Allen iN
|
6.258E-7
|
6.258E-5
|
5.086E-4
|
1.189E-3
|
6
|
65
|
20
|
80Dp SubClass 80Dp 5 Top 500 Cluster 1
|
80Dp SubClass 80Dp 5 Top 500 Cluster 1
|
Brain Map - Allen iN
|
1.153E-6
|
1.095E-4
|
8.900E-4
|
2.190E-3
|
6
|
72
|
21
|
GSM538329 500
|
alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3
|
Immgen.org, GSE15907
|
3.864E-6
|
3.496E-4
|
2.841E-3
|
7.342E-3
|
10
|
332
|
22
|
26Dp SubClass 26Dp 3 Top 500 Cluster 0
|
26Dp SubClass 26Dp 3 Top 500 Cluster 0
|
Brain Map - Allen iN
|
5.526E-6
|
4.772E-4
|
3.879E-3
|
1.050E-2
|
6
|
94
|
23
|
GSM538318 500
|
alpha beta T cells, NKT.4+.Lv, CD45 TCRb aGalCer-loaded CD1d tet CD4, Liver, avg-4
|
Immgen.org, GSE15907
|
6.310E-6
|
4.995E-4
|
4.060E-3
|
1.199E-2
|
10
|
351
|
24
|
GSM538325 500
|
alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4
|
Immgen.org, GSE15907
|
6.310E-6
|
4.995E-4
|
4.060E-3
|
1.199E-2
|
10
|
351
|
25
|
GSM605805 500
|
gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3
|
Immgen.org, GSE15907
|
2.682E-5
|
2.038E-3
|
1.656E-2
|
5.095E-2
|
10
|
415
|
26
|
26Dn SubClass 26Dn 3 Top 500 Cluster 0
|
26Dn SubClass 26Dn 3 Top 500 Cluster 0
|
Brain Map - Allen iN
|
2.998E-5
|
2.191E-3
|
1.781E-2
|
5.697E-2
|
5
|
76
|
27
|
GSM538309 500
|
NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3
|
Immgen.org, GSE15907
|
6.040E-5
|
4.230E-3
|
3.438E-2
|
1.148E-1
|
9
|
367
|
28
|
54Dp SubClass 54Dp 5 Top 500 Cluster 3
|
54Dp SubClass 54Dp 5 Top 500 Cluster 3
|
Brain Map - Allen iN
|
6.234E-5
|
4.230E-3
|
3.438E-2
|
1.184E-1
|
7
|
210
|
29
|
GSM605787 500
|
gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3
|
Immgen.org, GSE15907
|
8.883E-5
|
5.820E-3
|
4.730E-2
|
1.688E-1
|
9
|
386
|
30
|
PP MEG 100
|
PP MEG top-relative-expression-ranked 100
|
PCBC
|
1.117E-4
|
7.077E-3
|
5.752E-2
|
2.123E-1
|
5
|
100
|
31
|
GSM605761 500
|
alpha beta T cells, T.4.Sp.B16, 4+ 8- TCR+ 45+, B16 Melanoma Spleen, avg-2
|
Immgen.org, GSE15907
|
1.442E-4
|
8.840E-3
|
7.185E-2
|
2.741E-1
|
8
|
322
|
32
|
GSM538322 500
|
alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d tetramer CD4, Spleen, avg-1
|
Immgen.org, GSE15907
|
2.398E-4
|
1.424E-2
|
1.157E-1
|
4.556E-1
|
8
|
347
|
33
|
GSM538371 500
|
alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3
|
Immgen.org, GSE15907
|
3.014E-4
|
1.735E-2
|
1.410E-1
|
5.726E-1
|
8
|
359
|
34
|
GSM538300 500
|
NK cells, NK.H+.MCMV1.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3
|
Immgen.org, GSE15907
|
3.686E-4
|
2.060E-2
|
1.674E-1
|
7.004E-1
|
8
|
370
|
35
|
54Dp SubClass 54Dp 5 Top 500 Cluster 2
|
54Dp SubClass 54Dp 5 Top 500 Cluster 2
|
Brain Map - Allen iN
|
4.172E-4
|
2.265E-2
|
1.840E-1
|
7.926E-1
|
4
|
74
|
36
|
GSM476684 500
|
gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3
|
Immgen.org, GSE15907
|
4.555E-4
|
2.404E-2
|
1.954E-1
|
8.654E-1
|
8
|
382
|
37
|
GSM605790 500
|
gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3
|
Immgen.org, GSE15907
|
5.134E-4
|
2.636E-2
|
2.143E-1
|
9.754E-1
|
8
|
389
|
38
|
GSM605808 500
|
gamma delta T cells, Tgd.vg5-.act.IEL, CD8a+ CD8b- TCRd+ Vg5- CD44hi, Small Intestine, avg-3
|
Immgen.org, GSE15907
|
6.368E-4
|
3.175E-2
|
2.580E-1
|
1.000E0
|
8
|
402
|
39
|
GSM605796 500
|
gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3
|
Immgen.org, GSE15907
|
6.684E-4
|
3.175E-2
|
2.580E-1
|
1.000E0
|
8
|
405
|
40
|
GSM605811 500
|
gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3
|
Immgen.org, GSE15907
|
6.684E-4
|
3.175E-2
|
2.580E-1
|
1.000E0
|
8
|
405
|
41
|
GSM605840 500
|
Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3
|
Immgen.org, GSE15907
|
7.125E-4
|
3.275E-2
|
2.661E-1
|
1.000E0
|
8
|
409
|
42
|
GSM854297 500
|
Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2
|
Immgen.org, GSE15907
|
7.239E-4
|
3.275E-2
|
2.661E-1
|
1.000E0
|
8
|
410
|
43
|
GSM605843 500
|
Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3
|
Immgen.org, GSE15907
|
7.471E-4
|
3.301E-2
|
2.683E-1
|
1.000E0
|
8
|
412
|
44
|
GSM854299 500
|
Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
7.831E-4
|
3.382E-2
|
2.748E-1
|
1.000E0
|
8
|
415
|
45
|
GSM538210 500
|
B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21.35+, Spleen, avg-1
|
Immgen.org, GSE15907
|
9.016E-4
|
3.807E-2
|
3.094E-1
|
1.000E0
|
7
|
326
|
46
|
facebase RNAseq e14.5 palate poster proximal ERK2 WT 2500 K3
|
facebase RNAseq e14.5 palate poster proximal ERK2 WT 2500 K3
|
Gudmap RNAseq
|
9.737E-4
|
4.022E-2
|
3.269E-1
|
1.000E0
|
6
|
240
|
47
|
GSM403987 500
|
CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1
|
Immgen.org, GSE15907
|
1.112E-3
|
4.495E-2
|
3.653E-1
|
1.000E0
|
7
|
338
|
48
|
GSM538211 500
|
B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21/35+, Spleen, avg-2
|
Immgen.org, GSE15907
|
1.170E-3
|
4.575E-2
|
3.718E-1
|
1.000E0
|
7
|
341
|
49
|
gudmap kidney adult Mesangium Meis 200
|
kidney adult Mesangium Meis top-relative-expression-ranked 200
|
Gudmap Mouse MOE430.2
|
1.180E-3
|
4.575E-2
|
3.718E-1
|
1.000E0
|
5
|
167
|
50
|
GSM538365 500
|
alpha beta T cells, T.4Mem.Sp, 4+ 8- 25- 44hi 122lo, Spleen, avg-3
|
Immgen.org, GSE15907
|
1.210E-3
|
4.598E-2
|
3.737E-1
|
1.000E0
|
7
|
343
|
Show 45 more annotations
|
15: Computational [Display Chart]
166 annotations before applied cutoff / 9399 genes in category
|
16: MicroRNA [Display Chart]
556 annotations before applied cutoff / 19844 genes in category
|
17: Drug [Display Chart]
13308 annotations before applied cutoff / 22098 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
4345 UP
|
Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT HG-U133A
|
Broad Institute CMAP
|
2.251E-6
|
2.996E-2
|
3.018E-1
|
2.996E-2
|
8
|
198
|
|
18: Disease [Display Chart]
683 annotations before applied cutoff / 16150 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
umls:C0859942
|
Hanot's cirrhosis
|
DisGeNET Curated
|
3.746E-4
|
4.614E-2
|
3.278E-1
|
2.559E-1
|
2
|
8
|
2
|
20090331:Zemunik
|
Biochemical measures
|
GWAS
|
8.746E-4
|
4.614E-2
|
3.278E-1
|
5.974E-1
|
2
|
12
|
3
|
umls:C0392702
|
Abnormal involuntary movement
|
DisGeNET BeFree
|
1.575E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
2
|
16
|
4
|
umls:C0876991
|
Histiocytosis haematophagic
|
DisGeNET BeFree
|
2.229E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
2
|
19
|
5
|
umls:C0006845
|
Candidiasis, Chronic Mucocutaneous
|
DisGeNET Curated
|
2.470E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
2
|
20
|
6
|
umls:C0392788
|
Nasal Type Extranodal NK/T-Cell Lymphoma
|
DisGeNET BeFree
|
2.989E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
2
|
22
|
7
|
cv:CN219204
|
Immunodeficiency 30
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
8
|
cv:CN228398
|
TENORIO SYNDROME
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
9
|
cv:C0030360
|
Papillon-Lefèvre syndrome
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
10
|
611762
|
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2
|
OMIM
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
11
|
umls:C3810325
|
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
12
|
cv:CN184979
|
Spastic paraplegia 64, autosomal recessive
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
13
|
umls:C0153500
|
Malignant neoplasm of heart
|
DisGeNET BeFree
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
14
|
umls:C0030781
|
Peliosis Hepatis
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
15
|
umls:C1833809
|
OPTIC ATROPHY AND CATARACT, AUTOSOMAL DOMINANT
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
16
|
umls:C2675185
|
Kahrizi Syndrome
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
17
|
612556
|
ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1
|
OMIM
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
18
|
cv:C1855627
|
Haim-Munk syndrome
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
19
|
umls:C4015710
|
TENORIO SYNDROME
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
20
|
cv:C3151402
|
Candidiasis, familial, 5
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
21
|
cv:C1858968
|
Autoimmune lymphoproliferative syndrome, type 2
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
22
|
umls:C1858968
|
Autoimmune Lymphoproliferative Syndrome, Type IIA
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
23
|
20090225:Ling
|
Adiponectin levels
|
GWAS
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
24
|
umls:C1704251
|
Breast Lymphoma
|
DisGeNET BeFree
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
25
|
cv:C3151139
|
Retinitis pigmentosa 43
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
26
|
118400
|
CHERUBISM
|
OMIM
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
27
|
umls:C3151139
|
RETINITIS PIGMENTOSA 43
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
28
|
umls:C2675517
|
ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
29
|
170650
|
PERIODONTITIS, AGGRESSIVE, 1
|
OMIM
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
30
|
umls:C1262020
|
Diffuse alveolar damage
|
DisGeNET BeFree
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
31
|
245000
|
PAPILLON-LEFEVRE SYNDROME; PALS
|
OMIM
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
32
|
umls:C1283723
|
Deficiency of cathepsin C
|
DisGeNET BeFree
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
33
|
cv:C1833809
|
Optic atrophy and cataract, autosomal dominant
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
34
|
umls:C0342195
|
Thyroid Dyshormonogenesis 4
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
35
|
cv:C0008029
|
Fibrous dysplasia of jaw
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
36
|
cv:C0342195
|
Iodotyrosine deiodination defect
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
37
|
cv:C2675185
|
Kahrizi syndrome
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
38
|
umls:C4013949
|
IMMUNODEFICIENCY 30
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
39
|
cv:C0574084
|
3-Methylglutaconic aciduria type 3
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
40
|
umls:C3810289
|
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
41
|
cv:C2675517
|
Serum level of adiponectin 1
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
42
|
cv:C2673198
|
Familial cold autoinflammatory syndrome 2
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
43
|
umls:C0162375
|
Granuloma, Giant Cell Reparative
|
DisGeNET BeFree
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
44
|
274800
|
THYROID DYSHORMONOGENESIS 4; TDH4
|
OMIM
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
45
|
cv:C3150191
|
Congenital disorder of glycosylation type 1Q
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
46
|
umls:C2673198
|
Familial Cold Autoinflammatory Syndrome 2
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
47
|
603909
|
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A
|
OMIM
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
48
|
cv:C0031106
|
Periodontitis, aggressive, 1
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
49
|
cv:CN185373
|
Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis
|
Clinical Variations
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
50
|
umls:C3150191
|
Coloboma, Ocular, And Ichthyosis, Brain Malformations, And Endocrine Abnormalities
|
DisGeNET Curated
|
3.715E-3
|
4.614E-2
|
3.278E-1
|
1.000E0
|
1
|
1
|
Show 45 more annotations
|
|